Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Nephros (NEPH) Short-Term Debt repayments (2018 - 2020)

Nephros' quarterly Short-Term Debt repayments came in at $495000.0 in Q2 2020, up 661.54% quarter-over-quarter from $65000.0 in Q1 2020.

Nephros has reported Short-Term Debt repayments for 3 years, with the latest figure at $495000.0 in Q2 2020.

  • For the quarter ending Q2 2020, Short-Term Debt repayments changed N/A year-over-year to $495000.0; the trailing twelve-month figure through Dec 2020 stood at $560000.0 (down 42.27% YoY), and the FY2020 full-year result was $560000.0, up 29.93% from the prior year.
  • Short-Term Debt repayments for Q2 2020 stood at $495000.0, up from $65000.0 in the prior quarter.
  • The five-year high for Short-Term Debt repayments was $561000.0 in Q1 2018, with the low at -$10000.0 in Q3 2018.
  • Average Short-Term Debt repayments over 3 years is $255000.0, with a median of $243500.0 recorded in 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt repayments (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Nephros 38.93 Mn 34.91 Mn 2.99 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 495,000.00
Jun 30, 2020 495,000.00
Mar 31, 2020 65,000.00
Mar 31, 2020 65,000.00
Dec 31, 2019 422,000.00
Dec 31, 2019 422,000.00
Sep 30, 2018 -10,000.00
Sep 30, 2018 -10,000.00
Jun 30, 2018 -3,000.00
Jun 30, 2018 -3,000.00
Mar 31, 2018 561,000.00
Mar 31, 2018 561,000.00